| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―03 |
Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2 |
Daisuke Kawata, Hideyuki Iwai, Seiya Oba, Yoji Komiya, Ryuji Koike, Sho Miyamoto, Takayuki Kanno, Akira Ainai, Tadaki Suzuki, Tadashi Hosoya, Shinsuke Yasuda |
| 2 |
[GO] |
2024―Mar―29 |
Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study |
Mayoko Tsuji, Mitsuko Kondo, Yasuto Sato, Azusa Miyoshi, Fumi Kobayashi, Ken Arimura, Kaoru Yamashita, Satoshi Morimoto, Naoko Yanagisawa, Atsuhiro Ichihara, Etsuko Tagaya |
| 3 |
[GO] |
2024―Mar―19 |
Understanding long COVID myocarditis: A comprehensive review |
Arti Srivastava, Shankar Nalroad Sundararaj, Jagriti Bhatia, Dharamvir Singh Arya |
| 4 |
[GO] |
2024―Mar―02 |
Investigation of IL-6 serum level in COVID-19 patients with positive COVID-19 IgG/IgM antibody titers to check inflammation and disease progression |
Samaneh mollazadeh, Mahmoud Mahmoudi, Mojgan Mohammadi, Ramiar Kamal Kheder, Hussein Nasiri Mahallati, Salime Sarbaz Haghighi, Elnaz Masoumi, Zahra Javanmardi, Seyed-Alireza Esmaeili |
| 5 |
[GO] |
2024―Feb―17 |
Effect of SARS-CoV-2 and Toxoplasma gondii co-infection on IFN-γ and TNF-α expression and its impact on disease severity |
Magda S.A. Abdeltawab, Mohamed Fateen, Shimaa Saad El-Din, Riem M. Elmessiery, Osama Mohammady Mohamed, Khaled Marzouk Sadek, Engy Medhat, Alshaimaa M.R. Hamed |
| 6 |
[GO] |
2024―Feb―15 |
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients |
Jaime Carrillo-García, Serena Lacerenza, Nadia Hindi, David S. Moura, Gloria Marquina, Daniel Parra Corral, Jennifer Olalla, Juana María Cano Cano, Sergio Hoyos, Marta Renshaw, Jose L Mondaza-Hernández, Davide Di Lernia, Antonio Casado, Arantxa Manzano, Antonio Gutierrez, Javier Martin-Broto |
| 7 |
[GO] |
2024―Jan―31 |
Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection |
Fabiola Mestriner, Daniely F. Francisco, Ligia C.B. Campos, Ariel E.S. Couto, Thais F.C. Fraga-Silva, Vinicius Flora Dugaich, Carolina D Avila-Mesquita, Henrique Zukowski Kovacs, Jociany L. Vasconcelos, Elizabete R. Milani, Keyla Santos Guedes de Sá, Ronaldo Martins, Maria C. Jordani, Carlos A.C. Corsi, Jessyca M. Barbosa, Tauana Vasconcelos, Mayra Gonçalves Menegueti, Julio Neto, Rafael M. da Costa, Paulo R.B. Evora, Eurico Arruda, Rita Tostes, Katarzyna Polonis, Vania L.D. Bonato, Maria Auxiliadora-Martins, Mauricio S. Ribeiro, Christiane Becari |
| 8 |
[GO] |
2024―Jan―25 |
IL-6 is a predictor and potential therapeutic target for coronavirus disease 2019-related heart failure: A single-center retrospective study |
Yan Xi, Yu Mao, Wei Zhu, Peng Xi, Feifei Huang, Hongwei Tan, Xudong Liao, Lin Zhou |
| 9 |
[GO] |
2024―Jan―24 |
IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study |
Maha O. Hammad, Mahmoud M. Alseoudy, Asmaa M. Borg, Ahmed El-Mesery, Mohamed Elgamal, Dalia A. Abdelghany, Dina Elzeiny |
| 10 |
[GO] |
2024―Jan―19 |
Changes in markers of inflammation and their correlation with death in patients with COVID-19 in the intensive care unit |
Andressa de Azambuja Pias Weber, Fernanda Tibolla Viero, Micheli Mainardi Pillat, Thissiane de Lima Gonçalves |
| 11 |
[GO] |
2024―Jan―07 |
Do chemokine/chemokine receptor axes play paramount parts in trafficking and oriented locomotion of monocytes/macrophages toward the lungs of COVID-19 infected patients? A systematic review |
Merat Mahmoodi, Fatemeh Mohammadi Henjeroei, Gholamhossein Hassanshahi, Reza Nosratabadi |
| 12 |
[GO] |
2024―Jan―07 |
Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients |
Zahra Sefatjoo, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Shahrzad Shoraka, Mahsa Saeedi Niasar, Kaveh Baghaei, Anna Meyfour, Amir Sadeghi, Habib Malekpour, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali |
| 13 |
[GO] |
2023―Dec―22 |
Multi-faceted dysregulated immune response for COVID-19 infection explaining clinical heterogeneity |
Suman K. Paine, Parveena Choudhury, Mahabub Alam, Chandrika Bhattacharyya, Subhasish Pramanik, Devashish Tripathi, Chitrarpita Das, Vatsal Patel, Sayantan Ghosh, Sanjay Chatterjee, Lakshmi Kanta Mondal, Analabha Basu |
| 14 |
[GO] |
2023―Dec―20 |
Protective effects of IL18-105G > A and IL18-137C > G genetic variants on severity of COVID-19 |
Mayara Tiemi Enokida Mori, Andréa Name Colado Simão, Tiago Danelli, Sayonara Rangel Oliveira, Pedro Luis Candido de Souza Cassela, Guilherme Lerner Trigo, Kauê Morais Cardoso, Alexandre Mestre Tejo, Zuleica Naomi Tano, Elaine Regina Delicato de Almeida, Edna Maria Vissoci Reiche, Michael Maes, Marcell Alysson Batisti Lozovoy |
| 15 |
[GO] |
2023―Dec―05 |
Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients |
Mostafa Khafaei, Reza Asghari, Fariba Zafari, Morteza Sadeghi |
| 16 |
[GO] |
2023―Dec―01 |
Pyrogenic and inflammatory mediators are produced by polarized M1 and M2 macrophages activated with D-dimer and SARS-CoV-2 spike immune complexes |
Yun-Jong Park, David Acosta, Mohammad Rubel Hoq, Surender Khurana, Hana Golding, Marina Zaitseva |
| 17 |
[GO] |
2023―Nov―16 |
Cytokine storm in COVID-19 and malaria: Annals of pro-inflammatory cytokines |
Tabish Qidwai |
| 18 |
[GO] |
2023―Nov―15 |
Even one dose of tocilizumab could hinder bad prognosis of cytokines storm in COVID-19 patients |
Mohamed Abdel-Salam Elgohary, Asmaa Ali, Sumaiah J.Alarfaj, Hesham Shahin, Ashraf Ibrahim Zaki, Eman Medhat Hasan, Mohamed Emam Mohamed, Ahmad Mahmoud Elkholy, Thanaa A. El-Masry, Jacklin Samir kamal, Mohammed Ali AbdelRahim, Ashgan Wageh Saber, Mohamed G Seadawy, Mohamed H.M. Elshishtawy, Maisra M. El-Bouseary |
| 19 |
[GO] |
2023―Sep―13 |
Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19 |
Fatemeh Azarfar, Bahareh Abbasi, Amir Jalali, Mohammad Hadi Abbasian |
| 20 |
[GO] |
2023―Sep―08 |
Importance of screening severe COVID-19 patients for IFN-λ1, IL-6 and anti-S1 IgG levels |
Olcay Buse Kenanoğlu, Aytül Gül, Hüseyin Can, Muhammet Karakavuk, Sedef Erkunt Alak, Gülay Korukluoğlu, Ayşe Başak Altaş, Hüsnü Pullukçu, Aysu Değirmenci Döşkaya, Tuğba Karakavuk, Ceren Gül, Candan Çiçek, Mehmet Sezai Taşbakan, Akın Çinkooğlu, Cemal Ün, Adnan Yüksel Gürüz, Mahmut Avcı, Ercüment Karasulu, Şaban Tekin, Mert Döşkaya, Meltem Işıkgöz Taşbakan |
| 21 |
[GO] |
2023―Sep―06 |
The significance of IFITM3 polymorphism in COVID-19 asymptomatic and ICU admission Kurdish patients |
Peshnyar M.A. Rashid, Gaza F. Salih |
| 22 |
[GO] |
2023―Sep―05 |
Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients |
Débora Familiar-Macedo, Paulo Vieira Damasco, Victor Edgar Fiestas Solórzano, Joyce Carnevale Rodrigues, Elba Regina Sampaio de Lemos, Flávia Barreto dos Santos, Marilda Agudo Mendonça Teixeira de Siqueira, Elzinandes Leal de Azeredo, Luzia Maria de-Oliveira-Pinto |
| 23 |
[GO] |
2023―Aug―20 |
COVID-19 vaccination: Effects of immunodominant peptides of SARS-CoV-2 |
Arthur Gomes de Andrade, Fernando Cézar Comberlang, Luiz Henrique Agra Cavalcante-Silva, Tatjana Souza Lima Kessen |
| 24 |
[GO] |
2023―Aug―04 |
Characterization of the inflammatory response to COVID-19 illness in pregnancy |
Alexandra D. Forrest, Natalie E. Poliektov, Kirk A. Easley, Vasiliki Michopoulos, Meghna Ravi, Narayanaiah Cheedarla, Andrew S. Neish, Suneetha Cheedarla, John D. Roback, Anne L. Dunlop, Martina L. Badell, Carolynn M. Dude |
| 25 |
[GO] |
2023―Aug―01 |
A meta analysis on the utility of Anakinra in severe COVID-19 disease |
Aliae A.R. Mohamed Hussein, Reem Sayad, Abdelrahman Abdelshafi, Islam Abdelaal Hammam, Ahmed M. Kedwany, Shrouk Alaa-eldein Elkholy, Islam H. Ibrahim |
| 26 |
[GO] |
2023―Jun―26 |
Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects |
Renu Dharra, Anil Kumar Sharma, Sonal Datta |
| 27 |
[GO] |
2023―Jun―08 |
SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study |
Mohammad Sadegh Soltani-Zangbar, Mahsa Hajivalili, Danyal Daneshdoust, Sara Ghadir, Golaleh Savari, Mohammadali Zolfaghari, Leili Aghebati-Maleki, Solmaz Oloufi, Narjes Nouri, Naser Amini, Amir Mehdizadeh, Hossein Ghasemi Moghadam, Ata Mahmoodpoor, Javad Ahmadian Heris, Mehdi Yousefi |
| 28 |
[GO] |
2023―Jun―07 |
The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect |
Yousef Rasmi, ladan Jalali, Saliha Khalid, Ameneh Shokati, Poonam Tyagi, Alpaslan Ozturk, Amir Nasimfar |
| 29 |
[GO] |
2023―Jun―02 |
An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease |
Niv Samuel Mastboim, Alon Angel, Oded Shaham, Tahel Ilan Ber, Roy Navon, Einav Simon, Michal Rosenberg, Yael Israeli, Mary Hainrichson, Noa Avni, Eran Reiner, Paul Feigin, Kfir Oved, Boaz Tadmor, Pierre Singer, Ilya Kagan, Shaul Lev, Dror Diker, Amir Jarjou'I, Ramzi Kurd, Eli Ben-Chetrit, Guy Danziger, Sina A. Tegethoff, Cihan Papan, Sergey Motov, Ma'anit Shapira, Michal Stein, Tanya M Gottlieb, Eran Eden, Adi Klein |
| 30 |
[GO] |
2023―May―22 |
Impact of COVID-19 and vaccination on first and second trimester screening results |
Sedigheh Hantoushzadeh, Sarang Younesi, Mohammad Mahdi Taheri Amin, Pourandokht Saadati, So�h Jamali, Saina Nassiri, Mohammad-Hossein Modarresi, Shahram Savad, Saeed Delshad, Zahra Soleiman Meiguni, Saloomeh Amidi, Fariba Navidpour, Bahareh Yazdani, Ali Karimi Farani, Maasoumeh Saleh, Soudeh Ghafouri-Fard |
| 31 |
[GO] |
2023―Mar―24 |
Identification of key differentially expressed genes in SARS-CoV-2 using RNA-seq analysis with a systems biology approach |
Arash Safarzadeh, Bashdar Mahmud Hussen, Mohammad Taheri, Soudeh Ghaforui-Fard, Mohammadreza Hajiesmaeili |
| 32 |
[GO] |
2023―Mar―13 |
Type I and III interferons are good markers to monitor COVID-19 pathophysiology |
Dounia Darif, Rajaâ Ejghal, Christophe Desterke, Ahmed Outlioua, Ikram Hammi, Meryem Lemrani, Farida Hilali, Fadila Guessous, Younes Zaid, Khadija Akarid |
| 33 |
[GO] |
2023―Feb―16 |
T-cell lymphocytopenia: an omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections |
Jeffrey S. Putter, Jerard Seghatchian |
| 34 |
[GO] |
2022―Dec―14 |
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia |
Charilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, Eran Reiner, Maria Kosmidou, Ioanna Karanika, Vasileios Petrakis, George Adamis, Nikolaos K. Gatselis, Archontoula Fragkou, Aggeliki Rapti, Eleonora Taddei, Ioannis Kalomenidis, George Chrysos, Giulia Bertoli, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Evangelos Kostis, Lorenzo Dagna, Sofia Koukidou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Christina Trakatelli, George Tsoukalas, Carlo Selmi, Michael Samarkos, Athina Pyrpasopoulou, Aikaterini Masgala, Emmanouil Antonakis, Aikaterini Argyraki, Karolina Akinosoglou, Styliani Sympardi, Periklis Panagopoulos, Haralampos Milionis, Simeon Metallidis, Konstantinos N. Syrigos, Alon Angel, George N. Dalekos, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis |
| 35 |
[GO] |
2022―Dec―13 |
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection |
Leon Cords, Robin Woost, Silke Kummer, Thomas T. Brehm, Stefan Kluge, Stefan Schmiedel, Sabine Jordan, Ansgar W. Lohse, Marcus Altfeld, Marylyn M. Addo, Julian Schulze zur Wiesch, Claudia Beisel |
| 36 |
[GO] |
2022―Aug―29 |
A Meta-summary and Bioinformatic Analysis Identified Interleukin 6 as a Master Regulator of COVID-19 Severity Biomarkers |
Mohannad Ghanem, Sharon J Brown, Aysha EAT Mohamed, Heidi R Fuller |
| 37 |
[GO] |
2022―Aug―29 |
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden |
Louise Ziegler, Annika Lundström, Sebastian Havervall, Charlotte Thålin, Bruna Gigante |
| 38 |
[GO] |
2022―Aug―11 |
The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults |
Giuseppe Oliveto, Carolina Scagnolari, Federica Frasca, Leonardo Sorrentino, Luigi Matera, Raffaella Nenna, Agnese Viscido, Mirko Scordio, Laura Petrarca, Anna Maria Zicari, Elio Gentilini, Gabriella D'Ettorre, Giancarlo Ceccarelli, Fabio Midulla, Guido Antonelli, Alessandra Pierangeli |
| 39 |
[GO] |
2022―Jul―31 |
COVID-19 imparted immune manifestation can be combated by NLGP: Lessons from cancer research |
Anamika Bose, Rathindranath Baral |
| 40 |
[GO] |
2022―Jul―28 |
Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19 |
Sevgi Özcan, Esra Dönmez, Sevil Tuğrul Yavuz, Murat Ziyrek, Orhan İnce, H.Suat Küçük, Zeynep Atam Taşdemir, İshak Yılmaz, Sinan Varol, İrfan Şahin, Ertuğrul Okuyan |
| 41 |
[GO] |
2022―Jul―25 |
Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators |
Thalia Medeiros, Gabriel Macedo Costa Guimarães, Fabiana Rabe Carvalho, Lilian Santos Alves, Renan Faustino, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, Andréa Teixeira-Carvalho, Matheus de Souza Gomes, Laurence Rodrigues do Amaral, Olindo Assis Martins-Filho, Jocemir Ronaldo Lugon, Jorge Reis Almeida, Andrea Alice Silva |
| 42 |
[GO] |
2022―Jul―22 |
Is IFN expression by NK cells a hallmark of severe COVID-19? |
Bárbara Guimarães Csordas, Pedro Henrique de Sousa Palmeira, Rephany Fonseca Peixoto, Fernando Cézar Comberlang Queiroz Davis dos Santos, Isac Almeida de Medeiros, Fátima de Lourdes Assunção Araújo de Azevedo, Robson Cavalcante Veras, Daniele Idalino Janebro, Ian P.G. Amaral, José Maria Barbosa-Filho, Tatjana Souza Lima Keesen |
| 43 |
[GO] |
2022―Jul―18 |
Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals |
Clio P. Mavragani, Charalampos Skarlis, Ioannis V. Kostopoulos, Eirini Maratou, Paraskevi Moutsatsou, Evangelos Terpos, Ourania E. Tsitsilonis, Meletios-Athanasios Dimopoulos, Petros P. Sfikakis |
| 44 |
[GO] |
2022―Jul―02 |
Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality |
Iraj Ahmadi, Alireza Afifipour, Fatemeh Sakhaee, Mohammad Saber Zamani, Fahimeh Mirzaei Gheinari, Enayat Anvari, Abolfazl Fateh |
| 45 |
[GO] |
2022―Jun―07 |
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: From prognostic marker to therapeutic agent |
Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht |
| 46 |
[GO] |
2022―Apr―25 |
Cytokine response over the course of COVID-19 infection in pregnant women |
Daniel B. Rosen, Elisabeth A. Murphy, Ron S. Gejman, Allyson Capili, Rachel L. Friedlander, Sophie Rand, Kristen A. Cagino, Shannon M. Glynn, Kathy C. Matthews, Jeff M. Kubiak, Jim Yee, Malavika Prabhu, Laura E. Riley, Yawei J. Yang |
| 47 |
[GO] |
2022―Apr―19 |
Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population |
Sara Falahi, Mohammad Hossein Zamanian, Parisa Feizollahi, Alireza Rezaiemanesh, Farhad Salari, Zahra Mahmoudi, Ali Gorgin Karaji |
| 48 |
[GO] |
2022―Apr―05 |
SARS-CoV-2 triggering autoimmune diseases |
Leila Mobasheri, Mohammad Hossein Nasirpour, Elham Masoumi, Afsaneh Foolady Azarnaminy, Mozhdeh Jafari, Seyed-Alireza Esmaeili |
| 49 |
[GO] |
2022―Apr―04 |
Up-regulated Serum Levels of Interleukin (IL)-17A and IL-22 in Egyptian Pediatric Patients with COVID-19 and MIS-C: Relation to the Disease Outcome |
Gehan Ahmed Mostafa, Hanan Mohamed Ibrahim, Abeer Al Sayed Shehab, Sondos Mohamed Magdy, Nada AboAbdoun Soliman, Dalia Fathy El-Sherif |
| 50 |
[GO] |
2022―Mar―28 |
Clinical monitored in subjects metabolically healthy and unhealthy before and during a SARS-CoV-2 infection- A cross-sectional study in Mexican population |
Samuel Treviño, Steffany Cortezano-Esteban, Hugo Hernández-Fragoso, Alfonso Díaz, Rubén Vázquez-Roque, Victor Enrique Sarmiento-Ortega, Diana Moroni-González, Rosana Pelayo, Eduardo Brambila |
| 51 |
[GO] |
2022―Mar―04 |
Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients |
Mohammadarian Akbari, Mehdi Akhavan-Bahabadi, Navid Shafigh, Afshin Taheriazam, Bashdar Mahmud Hussen, Arezou Sayad, Mohadeseh Fathi, Mohammad Taheri, Soudeh Ghafouri-Fard, Mohammad Fathi |
| 52 |
[GO] |
2022―Feb―10 |
SARS-CoV-2 infection causes intestinal cell damage: Role of interferon’s imbalance |
Stefany Guimarães Sousa, Antônio Kleiton de Sousa, Cynthia Maria Carvalho Pereira, Anna Sofia Miranda Loiola Araújo, Diva de Aguiar Magalhães, Tarcisio Vieira de Brito, André Luiz dos Reis Barbosa |
| 53 |
[GO] |
2022―Feb―01 |
Hemoperfusion during veno-venous ECMO in severe COVID-19 with IL-6 elevation |
Giovanni Giordano, Francesco Alessandri, Francesco Pugliese |
| 54 |
[GO] |
2022―Jan―31 |
Elevated plasma levels of CXCL16 in severe COVID-19 patients |
Sandra P. Smieszek, Vasilios M. Polymeropoulos, Christos M. Polymeropoulos, Bartlomiej P. Przychodzen, Gunther Birznieks, Mihael H. Polymeropoulos |
| 55 |
[GO] |
2022―Jan―18 |
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis |
Laura Bergantini, Miriana d'Alessandro, Paolo Cameli, Ambra Otranto, Simona Luzzi, Francesco Bianchi, Elena Bargagli |
| 56 |
[GO] |
2021―Dec―25 |
Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients |
S. Ashrafzadeh-Kian, M.R. Campbell, J.C. Jara Aguirre, J. Walsh, A. Kumanovics, G. Jenkinson, P. Rinaldo, M.R. Snyder, A. Algeciras-Schimnich |
| 57 |
[GO] |
2021―Dec―14 |
Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis |
Anuradha Rajamanickam, Nathella Pavan Kumar, Padmapriyadarsini Chandrasekaran, Arul Nancy, P.K. Bhavani, Nandhini Selvaraj, Kushiyasri Karunanithi, Saravanan Munisankar, R. Srinivasan, Rachel Mariam Renji, Shanmuga Priya kumaravadivelu, Vijayalakshmi Venkatramani, Subash Babu |
| 58 |
[GO] |
2021―Nov―06 |
In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection |
Mehmet Hursitoglu, Nilgun Isıksacan, Betul Erismis, Faruk Karandere, Alev Kural, A.Baki Kumbasar, Kadriye Kart Yasar |
| 59 |
[GO] |
2021―Nov―06 |
Association and predictive value of biomarkers with severe outcomes in hospitalized patients with sars-cov-2 infection |
Rafael Fernandez-Botran, Stephen Furmanek, Raghava Sekhar Ambadapoodi, Evelyn Expósito González, Meredith Cahill, Ruth Carrico, Ozan Akca, Julio A. Ramírez |
| 60 |
[GO] |
2021―Oct―29 |
Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662] |
Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios M. Polymeropoulos, Bushra A. Mina, Christos M. Polymeropoulos, Mihael H. Polymeropoulos |
| 61 |
[GO] |
2021―Oct―06 |
Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: a prospective observational study |
Elena Sancho Ferrando, Katja Hanslin, Michael Hultström, Anders Larsson, Robert Frithiof, Miklos Lipcsey |
| 62 |
[GO] |
2021―Oct―06 |
IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
Chia Siang Kow, Abdullah Faiz Zaihan, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 63 |
[GO] |
2021―Sep―27 |
Randomized trial drug controlled compendious transcriptome analysis supporting broad and phase specific therapeutic potential of multiple candidates in COVID-19 |
Abhay Sharma |
| 64 |
[GO] |
2021―Sep―09 |
Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19) |
Aeshah A. Ahmed, Ali H. Ad'hiah |
| 65 |
[GO] |
2021―Sep―03 |
SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3 |
Wenwen Zhang, Zhenling Ma, Yaru Wu, Xixi Shi, Yanyan Zhang, Min Zhang, Menghao Zhang, Lei Wang, Wei Liu |
| 66 |
[GO] |
2021―Aug―06 |
COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? |
Claudio G. Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, Carlotta Pausini, Tommaso Guarniero, Wandong Hong, Enrico Giampieri, Ivan Corazza, Lari Federico, Dario de Biase, Maddalena Zippi, Marco Zancanaro |
| 67 |
[GO] |
2021―Jul―29 |
Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’ |
Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios Polymeropoulos, Christos Polymeropoulos, Mihael H. Polymeropoulos |
| 68 |
[GO] |
2021―Jul―03 |
Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study |
Sergey N. Avdeev, Natalia V. Trushenko, Natalia A. Tsareva, Andrey I. Yaroshetskiy, Zamira M. Merzhoeva, Galia S. Nuralieva, Galina V. Nekludova, Svetlana Yu. Chikina, Tatiana Yu. Gneusheva, Olga A. Suvorova, Anna E. Shmidt |
| 69 |
[GO] |
2021―Jul―03 |
Clinical Applications of Thrombopoietin Silencing: A Possible Therapeutic Role in COVID-19? |
Vincent J. Alentado, Alison R. Moliterno, Edward F. Srour, Melissa A. Kacena |
| 70 |
[GO] |
2021―Jul―03 |
Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease |
Nataša Todorović-Raković, Jonathan R. Whitfield |
| 71 |
[GO] |
2021―Jun―07 |
Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19 |
Takehiro Hasegawa, Atsushi Nakagawa, Kohjin Suzuki, Kazuto Yamashita, Saya Yamashita, Niina Iwanaga, Eiya Tamada, Kenta Noda, Keisuke Tomii |
| 72 |
[GO] |
2021―May―26 |
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? |
Gerwyn Morris, Chiara C Bortolasci, Basant K Puri, Wolfgang Marx, Adrienne O'Neil, Eugene Athan, Ken Walder, Michael Berk, Lisa Olive, Andre F. Carvalho, Michael Maes |
| 73 |
[GO] |
2021―May―24 |
Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients |
A. Gradin, H. Andersson, T. Luther, S. Bülow Anderberg, S. Rubertsson, M. Lipcsey, M. Åberg, A. Larsson, R. Frithiof, M. Hultström |
| 74 |
[GO] |
2021―Apr―19 |
Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19 |
Jie Geng, Feng Wang, Zhiwei Huang, Xiaobo Chen, Yuliang Wang |
| 75 |
[GO] |
2021―Apr―19 |
Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico |
Azalia Avila-Nava, Arturo Cortes-Telles, Darwin Torres- Erazo, Stephanie López-Romero, Rodolfo Chim Aké, Ana Ligia Gutiérrez Solis |
| 76 |
[GO] |
2021―Apr―01 |
Aberrant Cytokine Expression in COVID-19 Patients: Associations between Cytokines and Disease Severity |
Yueting Tang, Jiayu Sun, Huaqin Pan, Fen Yao, Yumeng Yuan, Mi Zeng, Guangming Ye, Gui Yang, Bokun Zheng, Junli Fan, Yunbao Pan, Ziwu Zhao, Shuang Guo, Yinjuan Liu, Fanlu Liao, Yongwei Duan, Xiaoyang Jiao, Yirong Li |
| 77 |
[GO] |
2021―Mar―27 |
IL-6 and IL-10 are associated with disease severity and a higher comorbidity in adults with COVID-19 |
Rafael Luís Luporini, Joice M. de A. Rodolpho, Lauro Tatsuo Kubota, Ana Carolina Baptista Moreno Martin, Marcia R. Cominetti, Fernanda de Freitas Anibal, Henrique Pott-Junior |
| 78 |
[GO] |
2021―Mar―26 |
Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019 |
Hao Chen, Rundong Qin, Zhifeng Huang, Wenting Luo, Peiyan Zheng, Huimin Huang, Haisheng Hu, Hui Wang, Baoqing Sun |
| 79 |
[GO] |
2021―Mar―20 |
Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019 |
Guo-Lin Wang, Hui-Xia Gao, Yu-Ling Wang, Xiao Wei, Yu-Zhen Liu, Jian-Hua Lu, Li Li, Hai-Bin Wang, Lei Zhao, Yan-Xiao Rong, Lin Yao, Li-Juan Duan, Benjamin D. Anderson, Mai-Juan Ma, Er-Hei Dai, Xiang-Na Zhao |
| 80 |
[GO] |
2021―Mar―14 |
Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication |
Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, Rajesh Kumar Kumawat, Ellora Sen |
| 81 |
[GO] |
2021―Mar―07 |
The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19 |
Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, Joachim Risse, Karsten Schmidt, Sivagurunathan Sutharsan, Christian Taube, Karl-Heinz Jöckel, Winfried Siffert, Andreas Kribben, Birte Möhlendick |
| 82 |
[GO] |
2021―Feb―23 |
Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: a review |
Benjamin M. Liu, Thomas B Martins, Lisa K. Peterson, Harry R. Hill |
| 83 |
[GO] |
2021―Feb―03 |
“The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction” |
Luca Giovanni Locatello, Chiara Bruno, Giandomenico Maggiore, Maria Cilona, Pietro Orlando, Giuseppe Fancello, Matteo Piccica, Iacopo Vellere, Filippo Lagi, Michele Trotta, Oreste Gallo |
| 84 |
[GO] |
2021―Jan―28 |
Prognostic bioindicators in severe COVID-19 patients |
L. Bergantini, E. Bargagli, M. d'Alessandro, R.M. Refini, P. Cameli, L. Galasso, C. Scapellato, F. Montagnani, S. Scolletta, F. Franchi, S. Valente, D. Bennett, G. Sebastiani, B. Frediani, F. Dotta |
| 85 |
[GO] |
2021―Jan―18 |
Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? |
Ramin Sami, Farshid Fathi, Nahid Eskandari, Meysam Ahmadi, Reza ArefNezhad, Hossein Motedayyen |
| 86 |
[GO] |
2021―Jan―18 |
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19 |
Wafa Sayah, Ismahane Berkane, Imène Guermache, Mohamed Sabri, Fatma Zahra Lakhal, Sarah Yasmine Rahali, Asma Djidjeli, Lydia mahammad Lamara, Fatma Merah, Brahim Belaid, Lilya Berkani, Nouzha Zhor Lazli, Lylia Kheddouci, Ahmed Kadi, Mourad Ouali, Rachida Khellafi, Dalila Mekideche, Assia Kheliouen, Réda Malek Hamidi, Soraya Ayoub, Nabil Beramtane raaf, Fawzi Derrar, Merzak Gharnaout, Ines Allam, Réda Djidjik |
| 87 |
[GO] |
2021―Jan―18 |
The Impact of COVID-19 Infection On The Cytokine Profile of Pregnant Women: A Prospective Case-Control Study |
Atakan Tanacan, Nuray Yazihan, Seyit Ahmet Erol, Ali Taner Anuk, Fatma Didem Yucel Yetiskin, Derya Biriken, A.Seval Ozgu-Erdinc, Huseyin Levent Keskin, Ozlem Moraloglu Tekin, Dilek Sahin |
| 88 |
[GO] |
2021―Jan―18 |
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia |
Luca Quartuccio, Martina Fabris, Arianna Sonaglia, Maddalena Peghin, Rossana Domenis, Adriana Cifé, Francesco Curcio, Carlo Tascini |
| 89 |
[GO] |
2021―Jan―18 |
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? |
Carolina Scagnolari, Camilla Bitossi, Agnese Viscido, Federica Frasca, Giuseppe Oliveto, Mirko Scordio, Laura Petrarca, Enrica Mancino, Raffaella Nenna, Elisabetta Riva, Corrado De Vito, Fabio Midulla, Guido Antonelli, Alessandra Pierangeli |
| 90 |
[GO] |
2020―Dec―16 |
Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients |
Sara Bülow Anderberg, Tomas Luther, Malin Berglund, Rolf Larsson, Sten Rubertsson, Miklos Lipcsey, Anders Larsson, Robert Frithiof, Michael Hultström |
| 91 |
[GO] |
2020―Dec―15 |
Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19 |
Allen Widysanto, Andree Kurniawan, Nata Pratama Hardjo Lugito, Mira Yuniarti, Catherine Gunawan, Jessica Wiryanto, Tasya Meidy Pradhana |
| 92 |
[GO] |
2020―Dec―11 |
Cytokine Storm Induced by SARS-CoV-2 Infection: The Spectrum of its Neurological Manifestations |
Parisorn Thepmankorn, John Bach, Ahmed Lasfar, Xilin Zhao, Sami Souayah, Zhao Zhong Chong, Nizar Souayah |
| 93 |
[GO] |
2020―Dec―09 |
A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19 |
Lelia Wagner, Walter E. Haefeli, Uta Merle, Hanns-Martin Lorenz, Nicolas Hohmann, Johanna Weiss, Dirk Theile |
| 94 |
[GO] |
2020―Nov―09 |
An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis |
Yili Liu, Daihong Chen, Junjie Hou, Haicong Li, Dan Cao, Mingquan Guo, Yun Ling, Menglu Gao, Yi Zhou, Yanmin Wan, Zhaoqin Zhu |
| 95 |
[GO] |
2020―Oct―23 |
The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19 |
Juan Gómez, Guillermo M. Albaiceta, Elías Cuesta-Llavona, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, Inés López-Alonso, Santiago Melón, Marta E. Alvarez-Argüelles, Helena Gil-Peña, José R. Vidal-Castiñeira, Viviana Corte-Iglesias, María L. Saiz, Victoria Alvarez, Eliecer Coto |
| 96 |
[GO] |
2020―Oct―12 |
Probable Positive Effects of the Photobiomodulation as an Adjunctive Treatment in COVID-19: A Systematic Review |
Marzieh Nejatifard, Sohrab Asefi, Raika Jamali, Michael R. Hamblin, Reza Fekrazad |
| 97 |
[GO] |
2020―Sep―30 |
Cytokine Profile and Disease Severity in Patients with COVID-19 |
Ali Ghazavi, Ali Ganji, Nafiseh Keshavarzian, Somayeh Rabiemajd, Ghasem Mosayebi |
| 98 |
[GO] |
2020―Sep―29 |
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19 |
Hasan Satış, Hasan Selçuk Özger, Pınar Aysert Yıldız, Kenan Hızel, Özlem Gulbahar, Gonca Erbaş, Gülbin Aygencel, Ozlem Guzel Tunccan, Mehmet Akif Öztürk, Murat Dizbay, Abdurrahman Tufan |
| 99 |
[GO] |
2020―Aug―20 |
ADE and hyperinflammation in SARS-CoV2 infection- Comparison with dengue hemorrhagic fever and feline infectious peritonitis |
Maryse Cloutier, Madhuparna Nandi, Awais Ullah Ihsan, Hugues Allard Chamard, Subburaj Ilangumaran, Sheela Ramanathan |
| 100 |
[GO] |
2020―Aug―15 |
A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases |
Abdullah Mahmud-Al-Rafat, Md. Muzammal Haque Asim, Andrew W. Taylor-Robinson, Apurba Majumder, Abdul Muktadir, Hasneen Muktadir, Mahbubul Karim, Imran Khan, Mohammad Mainul Ahasan, Md. Morsaline Billah |
| 101 |
[GO] |
2020―May―30 |
COVID-19 cytokine storm: The anger of inflammation |
Mehdi Mahmudpour, Jamshid Roozbeh, Mohsen Keshavarz, Shokrollah Farrokhi, Iraj Nabipour |
| 102 |
[GO] |
2020―May―21 |
Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions |
Rezvan Noroozi, Wojciech Branicki, Krzysztof Pyrc, Paweł P. Łabaj, Ewelina Pospiech, Mohammad Taheri, Soudeh Ghafouri-Fard |
|
